Invention Grant
- Patent Title: Immunomodulation by IAP inhibitors
-
Application No.: US15675987Application Date: 2017-08-14
-
Publication No.: US10786491B2Publication Date: 2020-09-29
- Inventor: Leigh Zawel , Christopher S. Straub , Brant G. Firestone , Glenn Dranoff , Michael Dougan
- Applicant: Novartis AG , Dana-Farber Cancer Institute, Inc.
- Applicant Address: CH Basel US MA Boston
- Assignee: NOVARTIS AG,DANA-FARBER CANCER INSTITUTE, INC.
- Current Assignee: NOVARTIS AG,DANA-FARBER CANCER INSTITUTE, INC.
- Current Assignee Address: CH Basel US MA Boston
- Agency: Brinks Gilson & Lione
- Agent Yuezhong Feng
- Main IPC: A61K39/39
- IPC: A61K39/39 ; A61K31/427 ; A61K31/4439 ; A61K31/421 ; A61K31/506 ; A61K39/00 ; C12N5/078

Abstract:
The present invention is directed to immune adjuvants containing IAP inhibitors, including Smac mimetics. The invention further provides pharmaceutical compositions and vaccines containing an IAP inhibitor and an antigen. Methods of enhancing an immune response by administration of an IAP inhibitor, methods of treating or preventing cancer, methods of treating or preventing infections, methods of treating autoimmune disorders, and methods of potentiating cytokine or antibody production are also provided.
Public/Granted literature
- US20170368047A1 Immunomodulation by IAP Inhibitors Public/Granted day:2017-12-28
Information query